AstraZeneca PLC
1337.50
24-4月-25 11:24:56
15 分の遅延
株式
+11.50
+0.87%
本日の幅
1314.00 - 1338.00
ISIN
N/A
ソース
Cboe
-
AstraZeneca's Datopotamab Deruxtecan Applications Validated In EU For Lung Cancer, Breast Cancer
04 3 2024 03:26:38 提供 NASDAQ US Markets
-
AstraZeneca: Voydeya Recommended For Approval In The EU By CHMP - Quick Facts
26 2 2024 02:56:02 提供 NASDAQ US Markets
-
AstraZeneca Prices $5bln Four Tranche Notes Offering
22 2 2024 03:24:41 提供 NASDAQ US Markets
-
20 2 2024 12:22:37 提供 NASDAQ Stocks
-
20 2 2024 12:17:15 提供 NASDAQ US Markets
-
Ex-Dividend Reminder: Avista, ONE Gas and AstraZeneca
20 2 2024 11:29:26 提供 NASDAQ Stocks
-
Ex-Dividend Reminder: Avista, ONE Gas and AstraZeneca
20 2 2024 11:25:27 提供 NASDAQ US Markets
-
AstraZeneca's Tagrisso With Chemotherapy Approved In US To Treat Lung Cancer
19 2 2024 04:46:28 提供 NASDAQ US Markets
-
AstraZeneca Enters Oversold Territory
12 2 2024 13:12:53 提供 NASDAQ Stocks
-
AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript
08 2 2024 16:26:03 提供 NASDAQ US Markets
-
Ionis Says Eplontersen Got Fast Track Status To Treat Transthyretin-mediated Amyloid Cardiomyopathy
08 2 2024 08:43:49 提供 NASDAQ US Markets
-
AstraZeneca Q4 Profit Rises; Revenue Ex COVID-19 Up 16% At CER
08 2 2024 02:49:12 提供 NASDAQ US Markets
-
AstraZeneca's (AZN) sBLA for Enhertu Gets FDA's Priority Tag
30 1 2024 09:02:12 提供 NASDAQ Stocks
-
AstraZeneca: FDA Grants ENHERTU Priority Review For Metastatic HER2-Positive Solid Tumors
29 1 2024 08:32:09 提供 NASDAQ US Markets
-
AZN March 8th Options Begin Trading
25 1 2024 11:49:47 提供 NASDAQ Stocks
-
AstraZeneca Says AIRSUPRA Now Commercially Available In US As FDA-approved Option For Asthma
22 1 2024 07:32:47 提供 NASDAQ US Markets
-
Compugen To Receive $10 Mln Payment After Dosing First Patient In AstraZeneca's ARTEMIDE-Bil01 Trial
08 1 2024 08:09:47 提供 NASDAQ US Markets
-
Bullish Two Hundred Day Moving Average Cross - AZN
04 1 2024 11:38:29 提供 NASDAQ Stocks
-
Bullish Two Hundred Day Moving Average Cross - AZN
04 1 2024 11:34:42 提供 NASDAQ US Markets
-
Allorion Therapeutic Inks Agreement With AstraZeneca For EGFR L858R Allosteric Inhibitor Program
02 1 2024 09:45:15 提供 NASDAQ US Markets